NASDAQ:CBAY
USD
32.48
- (0.03%)
CYMABAY THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 21 March 2024 GMT-4
USD 32.48
- (0.03%)
End of Day: 21 March 2024 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in p...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices